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On the Clot-Promoting Activity of Human Platelets in a
One-Stage Prothrombinase Assay
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Abstract. The procoagulant activity of activated platelets in a one-stage prothrombinase
assay is reevaluated. It is shown that the apparent procoagulant activity ofplatelets activated
by ADP or collagen can be explained by minor cell lysis accompanying platelet activation.
The reduction in clotting time observed with thrombin activated platelets can be explained by
a combined eflect of minor cell lysis and release and activation of factor V from the platelets.
Platelets stimulated by ionophore 423187 or by the combined action of collagen plus throm-
bin show a much shorter clotting time than can be accounted for by minor platelet lysis or
release and activation of factor V from the platelets.
The results with this clotting assay essentially confirm previous observations [Bevers et al.:
Eur. J. Biochem. 122: 429436,19821using a spectrophotometric method with highly purifred
coagulation fagtors and a chromogenic substrate to measure the rate of thrombin formation
with activated platelets.
Introduction
The ability of activated platelets to reduce
the clotting time in coagulation assays that
are sensitive to procoagulant phospholipids
has been well established [-3]. However,
clotting assays in the presence ofplatelets are
known to be sensitive to low percentages of
cell lysis [3], and to release and activation of
factor V from the platelets [4]. We have
recently shown, using a chromogenic sub-
strate assay with highly purified coagulation
factors, that platelets stimulated by the com-
bined action of collagen plus thrombin
strongly increase the rate offactor X and pro-
thrombin activation, as compared to nonac-
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Fig. 1. Clotting time of sonicated platelets as a
function of percentage lysis produced by sonication.
Clotting was measured in the absence of added factor
Va (see text). The longest clotting time shown (114 s)
corresponds to 0.4o/o of lysis; non sonicated platelets
had a clotting time of 178 s, Data are shown for one
representative platelet preparation.
Results
Figure I shows the relationship between
the clotting time (in the absence of excess
added factor Va) and the amount of platelet
lysis. Platelet lysis was induced by sonication
of washed platelet suspensions for various
time periods at a minimal output of the son-
ifier. Lysis, measured by the activity of lac-
tate dehydrogenase in the supernatant, was
expressed as a percentage of this enzyme
activity in a completely lysed platelet prepa-
ration. Addition of intact platelets to the
assay system hardly affects the clotting time
(see also table I) although this might differ
from one platelet preparation to another, de-
pending on the amount of lysed platelets
already present in the nonsonicated prepara-
tion. Trace amounts of lysed platelets induce
a significant decrease in clotting time. A non-
linear relationship between clotting time and
platelet lysis is obtained. The decrease in
clotting time produced by 10/o lysis in the
platelets is more than half of that observed
with a completely lysed platelet preparation.
A similar nonlinear relationship (with
shorter clotting times) was obtained in the
presence of an excess of exogenously added
factor Va (compare table I).
The effect of a lO-min activation period
with different agonists on the procoagulant
activity of intact washed human platelets is
given in table I. Platelets contain factor V
which can be released and activated as a
result of the action of some platelet agonists
[1 3-1 5]. Because factor Va is a cofactor in the
activation of prothrombin, this might inter-
fere with the coagulation assay. Therefore,
the assay was carried out either in the ab-
sence or in the presence of exogenously
added excess of factor Va. As a result of the
addition of factor Va, the rate of thrombin
formation will be increased leading to a de-
crease in clotting time. Also, the blank clot-
ting time with buffer instead of platelets is
significantly lowered in the presence of added
factor Va. Addition of nonstimulated plate-
lets hardly affects the blank clotting time,
either with or without added factor Va in the
assay. Since minor amounts of platelet lysis
strongly shorten the clotting time and some
platelet lysis accompanies platelet activation,
it will be clear that for an evaluation of the
clot-promoting eflect of activated platelets a
control for the contribution of lysed cells in
the assay is an essential requirement.
When platelets stimulated by ADP or col-
lagen are used in the clotting assay (either in
the presence or absence ofexogenously added
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Table I. Percentage oflysis in and clotting time ofsonicated and activated platelets
Sonication time, or platelet activator
(final concentration)
Lysis
o/o
Clotting time, s
absence of presence of
excess factor Va excess factor Va
Buffer
Platelets (not activated or sonicated)
I s sonication
3 s sonication
6 s sonication
l0 s sonication
I 2 s sonication
3 min sonication
ADP (10 pM)
Collagen (10 Uelml)
Thrombin (2 nM)
Collagen + thrombin
A^23187 (3 W)
t . ,
5 . 1
I  1 .9
t9.2
24.9
100
1 . 1
1 .9
1 .7
1 .6
2.7
r93
189
79
57
44
38
35
z 5
l l 5
98
49
38
3 l
27
25
l 8
54
48
49
29
Z J
90
76
57
35
27
Due to minor variations in the amount of lysis, data are given for one representative platelet preparation. In
total, 17 platelet preparations were tested that with two exceptions all showed a similar behavior.
factor Va), the reduction in clotting time
closely corresponds to that ofsonicated prep-
arations that show the same amount of lysis
as produced during the activation procedure.
Similar results were obtained with platelets
activated with serotonin, epinephrine or
kaolin (data not shown). Without added fac-
tor Va in the clotting assay, thrombin-acti-
vated platelets show a shorter clotting time
than can be accounted for by lysis, but this
discrepancy disappears in the presence of an
excess ofexogenous factor Va. This strongly
suggests that in the absence of added factor
Va the reduction in clotting time is not only
caused by minor cell lysis (some l.7olo) but
also by release and activation offactor Va. It
should be noted here that according to the
data of Chesney et al. [15], 0.1 ml of platelets
(108 cells/ml) used in the assay can contribute
approximately I unit of factor V when this
factor is fully released and activated into fac-
tor Va. The small amount of thrombin used
to activate the platelets does not significantly
affect the clotting time in this assay system.
In contrast to the platelet activations de-
scribed above, platelets stimulated by
A23187 or by the combined action of colla-
gen plus thrombin produce a much shorter
clotting time (both in the absence or presence
ofadded factor Va) than can be accounted for
by minor cell lysis and/or release and activa-
tion offactor V from the platelets.
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Discussion
The clotting time observed in a one-stage
prothrombinase assay using Russell's viper
venom will be dependent on the availability
of negatively charged procoagulant phospho-
lipids for the formation of the prothrom-
binase complex [16]. In the platelet plasma
membrane, the negatively charged phospho-
lipids are almost exclusively present in the
inner leaflet of the membrane [l7, l8]. This
explains why a preparation of intact non-
stimulated platelets does not significantly
shorten the clotting time. Platelet damage,
leading to the exposure ofthe inner surface of
the plasma membrane, thereby offering a
negatively charged phospholipid surface for
the formation of the prothrombinase com-
plex, results in a decrease in clotting time.
Lowering of the clotting time by the addi-
tion of activated platelets in the coagulation
assay can have at least three different expla-
nations: (i) release and activation offactor V
from the platelet o,-granules ince the plasma
mixture offered in the coagulation assay nor-
mally does not contain an excess of this fac-
tor and hence is sensitive to the addition of
factor Va; (ii) exposure of the negatively
charged inner surface of the platelet plasma
membrane as a result of lysis caused by the
activation procedure; (iii) exposure of nega-
tively charged phospholipids at the platelet
outer surface as a result of rearrangements in
the plasma membrane caused by the agonist-
receptor interaction. The data presented here
show that the decrease in clotting time caused
by ADP or collagen-activated platelets can be
explained by platelet lysis. It should be em-
phasized, however, that lysis was measured
by the activity of the cytoplasmic enzyme
lactate dehydrogenase in the platelet superna-
tant after activation. Therefore, it cannot be
excluded that the presence of this enzyme in
the supernatant is a result ofa transient leak-
age and does not necessarily reflect platelet
damage and exposure of the inner surface of
the plasma membrane. However, the close
correlation in clotting time between platelets
lysed by sonication and platelet lysis pro-
duced by certain agonists strongly suggests
that percentage leakage oflactate dehydroge-
nase during platelet activation in fact reflects
percentage of cell damage.
The effect ofrelease and activation offac-
tor V from the platelet granules can be of
importance only in those cases where plate-
lets are activated by thrombin or a combina-
tion of another agonist with thrombin. This
can be seen in table I comparing the reduc-
tion in clotting time between platelets acti-
vated with collagen and platelets activated
with thrombin. In the absence of exogenously
added extra factor Va the assay will be sensi-
tive to factor Va from the platelets. Although
activation by collagen results in a similar per-
centage of lysis as activation by thrombin,
the clotting time observed with thrombin-
activated platelets is shorter than that ob-
served with collagen-activated platelets. This
can be explained by the release and activa-
tion of factor V from the platelets which
occurs upon activation with thrombin. (Col-
lagen only induces release but not activation
of factor V.) When an excess of factor Va is
added to the assay, the difference in clotting
time between collagen- and thrombin-acti-
vated platelets disappears, and equals that of
sonicated preparations showing the same
amount of lysis.
Addition of platelets activated by a com-
bination of collagen plus thrombin produces
an even further reduction in clotting time,
which cannot be explained by either cell lysis
or release and activation of factor V. It has
Clotting Activity of Platelets z l 5
been shown previously that this actiyation
procedure exposes negatively charged phos-
pholipids (particularly phosphatidylserine) at
the cell outer surface, as a result of transbi-
layer movement of phospholipids by a pro-
cess not involving lysis of the cells [5]. It is
suggested that this process is in fact mainly
responsible for the observed reduction ofthe
clotting time with platelets activated by colla-
gen plus thrombin. A similar explanation can
be given for platelets activated by ionophore
423187.
It should be mentioned that the concen-
trations of the agonists used were all sufli-
cient to produce optimal release and aggrega-
tion, i.e no increase in o,-granula or dense
body release or in the extent of aggregation
was observed upon increasing the agonist
concentration. Also, the effect of the com-
bined action of collagen plus thrombin could
not be evoked by using higher thrombin con-
centrations to activate the platelets, or com-
binations of thrombin with other agonists.
The data obtained with this clotting assay
are in close agreement with those obtained
using an assay system with purified coagula-
tion factors and a chromogenic substrate to
measure the rate of thrombin formation in
the presence of activated platelets [5]. Al-
though care must be taken with the interpre-
tation of clotting times with respect o lysis of
the platelets or release and activation offac-
tor V, the assay described here is suitable to
determine whether or not negatively charged
phospholipids become exposed at the platelet
outer surface as a result of activation by a
platelet agonist.
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